EPISODE · Jun 19, 2024 · 23 MIN
Using Generative AI to Produce Precise Gene Editors
from The Bio Report · host Levine Media Group
Earlier this year, Profluent announced it had edited the human genome with OpenCRISPR-1, the world’s first AI-created and open-source gene editor. Though the open-source aspect helped garner attention for Profluent, it also served as a demonstration of the company’s generative AI platform to create novel CRISPR gene editors. We spoke to Hilary Eaton, chief business officer for Profluent, about how the company’s generative AI engine works, its business model, and why its platform has the potential to create other protein therapeutics of varying modalities.
What this episode covers
Hilary Eaton, chief business officer for Profluent, discusses the company’s generative AI engine to produce CRISPR enzymes, its business model, and why its platform has the potential to create other protein therapeutics of varying modalities.
NOW PLAYING
Using Generative AI to Produce Precise Gene Editors
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m